T1143 A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Testing CCX282-B in the Treatment of Celiac Disease

Gordon Hamilton; Markku Mäki; Marja-leena Lahdeaho; Madhuri Bhasin; Pirow Bekker; Thomas J. Schall

doi:10.1016/s0016-5085(08)62302-1

T1143 A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Testing CCX282-B in the Treatment of Celiac Disease

Gastroenterology ◽

10.1016/s0016-5085(08)62302-1 ◽

2008 ◽

Vol 134 (4) ◽

pp. A-493

Author(s):

Gordon Hamilton ◽

Markku Mäki ◽

Marja-leena Lahdeaho ◽

Madhuri Bhasin ◽

Pirow Bekker ◽

...

Keyword(s):

Celiac Disease ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double‐Blind , Placebo‐Controlled , Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study

The Oncologist ◽

10.1634/theoncologist.2020-0679 ◽

2020 ◽

Vol 25 (11) ◽

Author(s):

Richard F. Riedel ◽

Karla V. Ballman ◽

Yao Lu ◽

Steven Attia ◽

Elizabeth T. Loggers ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Refractory

Download Full-text

Updated report: A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402)

Annals of Oncology ◽

10.1093/annonc/mdw370.95 ◽

2016 ◽

Vol 27 ◽

pp. vi180

Author(s):

S. Yuki ◽

Y. Komatsu ◽

H. Satake ◽

Y. Miyamoto ◽

H. Tanioka ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　– A Randomized, Double-Blind, Placebo-Controlled Phase II Study –

Circulation Journal ◽

10.1253/circj.cj-15-1112 ◽

2016 ◽

Vol 80 (3) ◽

pp. 668-676 ◽

Cited By ~ 18

Author(s):

Hiroyuki Tsutsui ◽

Shinichi Momomura ◽

Akira Yamashina ◽

Hisao Ogawa ◽

Hiroaki Shimokawa ◽

...

Keyword(s):

Heart Failure ◽

Heart Rate ◽

Chronic Heart Failure ◽

Phase Ii ◽

Rate Control ◽

Phase Ii Study ◽

Japanese Patients ◽

Heart Rate Control ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of Additional 200-mg Dose of Celecoxib in Adult Patients With Postoperative Pain Following Extraction of Impacted Third Mandibular Molar: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Japan

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.01.004 ◽

2012 ◽

Vol 34 (2) ◽

pp. 314-328 ◽

Cited By ~ 10

Author(s):

Ken‘ichi Saito ◽

Akihiro Kaneko ◽

Katsuyuki Machii ◽

Hiroyoshi Ohta ◽

Masayuki Ohkura ◽

...

Keyword(s):

Postoperative Pain ◽

Phase Ii ◽

Phase Ii Study ◽

Adult Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Mandibular Molar

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-1558 ◽

2017 ◽

Vol 24 (2) ◽

pp. 316-325 ◽

Cited By ~ 7

Author(s):

Axel Grothey ◽

Jonathan R. Strosberg ◽

Lindsay A. Renfro ◽

Herbert I. Hurwitz ◽

John L. Marshall ◽

...

Keyword(s):

Colorectal Cancer ◽

Supportive Care ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Best Supportive Care ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia

Molecular Therapy ◽

10.1016/j.ymthe.2019.10.017 ◽

2019 ◽

Vol 27 (12) ◽

pp. 2158-2165 ◽

Cited By ~ 4

Author(s):

Yongquan Gu ◽

Shijun Cui ◽

Qi Wang ◽

Changjian Liu ◽

Bi Jin ◽

...

Keyword(s):

Growth Factor ◽

Hepatocyte Growth Factor ◽

Phase Ii ◽

Critical Limb Ischemia ◽

Phase Ii Study ◽

Limb Ischemia ◽

Double Blind ◽

Double Blind Placebo ◽

Hepatocyte Growth

Download Full-text

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

Advances in Therapy ◽

10.1007/s12325-020-01538-0 ◽

2020 ◽

Author(s):

Lowell L. Hart ◽

Renata Ferrarotto ◽

Zoran G. Andric ◽

J. Thaddeus Beck ◽

Janakiraman Subramanian ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Bispectral index-guided sedation with dexmedetomidine in intensive care: A prospective, randomized, double blind, placebo-controlled phase II study*

Critical Care Medicine ◽

10.1097/00003246-200205000-00009 ◽

2002 ◽

Vol 30 (5) ◽

pp. 1007-1014 ◽

Cited By ~ 118

Author(s):

Andreas E. Triltsch ◽

Martin Welte ◽

Peter von Homeyer ◽

Jochen Groe ◽

Arka Genähr ◽

...

Keyword(s):

Intensive Care ◽

Phase Ii ◽

Bispectral Index ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A twelve-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging, phase II study to assess the clinical efficacy of alosetron (GR68755) in male subjects with irritable bowel syndrome

The American Journal of Gastroenterology ◽

10.1016/s0002-9270(01)03784-4 ◽

2001 ◽

Vol 96 (9) ◽

pp. S317 ◽

Cited By ~ 1

Author(s):

E EDWARDS1

Keyword(s):

Irritable Bowel Syndrome ◽

Phase Ii ◽

Clinical Efficacy ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Dose Ranging ◽

Irritable Bowel ◽

Male Subjects

Download Full-text

Nintedanib plus pemetrexed/cisplatin followed by maintenance nintedanib for unresectable malignant pleural mesothelioma (MPM): An international, multicenter, randomized, double-blind, placebo-controlled phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps7612 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS7612-TPS7612 ◽

Cited By ~ 1

Author(s):

Giorgio V. Scagliotti ◽

Natasha B. Leighl ◽

Anna K. Nowak ◽

Nick Pavlakis ◽

Sanjay Popat ◽

...

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Study ◽

Pleural Mesothelioma ◽

Double Blind ◽

Double Blind Placebo ◽

International Multicenter

Download Full-text

T1143 A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Testing CCX282-B in the Treatment of Celiac Disease

A Randomized, Double‐Blind , Placebo‐Controlled , Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study

Updated report: A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402)

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure – A Randomized, Double-Blind, Placebo-Controlled Phase II Study –

Efficacy and Safety of Additional 200-mg Dose of Celecoxib in Adult Patients With Postoperative Pain Following Extraction of Impacted Third Mandibular Molar: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Japan

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

Bispectral index-guided sedation with dexmedetomidine in intensive care: A prospective, randomized, double blind, placebo-controlled phase II study*

A twelve-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging, phase II study to assess the clinical efficacy of alosetron (GR68755) in male subjects with irritable bowel syndrome

Nintedanib plus pemetrexed/cisplatin followed by maintenance nintedanib for unresectable malignant pleural mesothelioma (MPM): An international, multicenter, randomized, double-blind, placebo-controlled phase II study.

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　– A Randomized, Double-Blind, Placebo-Controlled Phase II Study –